Lifshitz Law Firm, P.C. Announces Investigation of ARA, BBIO, EIDX, CIT, EMIS, FCNCA, FCNCB, EV, MS, NAV, STND, and WTRE

by Newsfeed


NEW YORK, Dec. 17, 2020 /PRNewswire/ —  

American Renal Associates Holdings, Inc. (NYSE: ARA)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of ARA to affiliates of Nautic Partners for $11.50 per share.

If you are an investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at [email protected].

BridgeBio Pharma, Inc. (NASDAQ: BBIO) – Eidos Therapeutics, Inc. (EIDX)

Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of EIDX to BBIO for approximately $73.26 per share.

If you are an investor, and would like additional information about our…



Read Full Article Here